Kurma Partners S.A.

Kurma Partners, Bpifrance launch French incubator to turn translational projects across Europe into biotech start-ups

IO Biotech parlayed early clinical data into a €127 million ($154.8 million) series B financing led by HBM Healthcare Investments, which will support a Phase II trial of its leading cancer

Novavax Inc. (NASDAQ:NVAX) hired Gregory Covino as EVP and CFO as the company prepares to commercialize COVID-19 vaccine candidate NVXCoV2373 and flu vaccine NanoFlu. Covino succeeds EVP John

Kurma is the latest European life sciences VC to raise a record fund

ImCheck’s $53M series B will bring at least one T cell-activating antibody to the clinic, broaden immuno-oncology pipeline

French VC’s company creation office in Munich yields first start-up, a Max Planck Institute spinout

How French VC Kurma plans to turn German research into biotechs